Hinova pharmaceuticals usa inc
WebbHsk3486 - Haisco-USA Pharmaceutical Company, Inc. HSK3486 Product Profile Mechanism of Action: The primary mechanism of action for HSK3486 is to increase chloride ion influx through the gamma-aminobutyric acid receptor subtype A (GABAᴀ)-mediated ion channels to achieve central nervous system (CNS) depression Webb27 okt. 2024 · Hinova Pharmaceuticals Inc. reported earnings results for the nine months ended September 30, 2024. For the nine months, the company reported net loss was CNY 222.53 million compared to CNY 209.87... December 29, 2024
Hinova pharmaceuticals usa inc
Did you know?
Webb31 dec. 2024 · HINOVA PHARMACEUTICALS INC. (688302) Add to my list Report Summary Quotes Charts News Ratings Calendar Company Financials Consensus Revisions Funds Summary Most relevant All News Other languages Press Releases Official Publications Sector news All news about HINOVA PHARMACEUTICALS INC. … WebbHinova Pharma is an innovative drug research and development manufacturer that provides users with compound HC-1119 androgen receptor (AR) antagonism by using …
Webb31 dec. 2024 · Hinova Pharmaceuticals Inc is a Chinese company mainly engaged in the research and development of innovative drugs for critical illnesses. The Company … WebbHinova Pharmaceuticals Inc. researches and develops drugs. The Company focuses cancer and metabolic diseases innovative drugs. Hinova Pharmaceuticals serves …
WebbFounded Date 2013. Founders Xinghai Li, Yuanwei Chen. Operating Status Active. Last Funding Type Series C. Also Known As Haichuang Pharmaceutical , 海创药业, Haichuang Yaoye, 成都海创药业有限公司. Legal Name Hinova Pharmaceuticals Inc. Company Type For Profit. Phone Number (028) 8505 8465. Hinova Pharma is an innovative drug ...
Webb28 okt. 2024 · BOSTON, Oct. 28, 2024 /PRNewswire/ -- Hinova Pharmaceuticals Inc. (STAR: 688302), a clinical-stage biopharmaceutical company focused on developing …
Webb31 dec. 2024 · End-of-day quote Shanghai Stock Exchange - 2024-03-30. 53.99. CNY. -0.53%. 02/27. Hinova Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2024. CI. 02/10. Hinova Pharma Gets Regulatory Nod for Anti-Tumor Drug Trial. steinway st nycWebbFind the latest Hinova Pharmaceuticals Inc. (688302.SS) stock quote, history, news and other vital information to help you with your stock trading and investing. steinway s pianoWebb14 apr. 2024 · Hinova Pharmaceuticals Inc (688302:SHH) company profile with history, revenue, mergers & acquisitions, peer analysis, institutional shareholders and more. Hinova Pharmaceuticals Inc,... pin on sandy thomas illustrationsWebb27 feb. 2024 · Hinova Pharmaceuticals Inc. reported earnings results for the full year ended December 31, 2024. For the full year, the company reported sales was CNY 1.65 million. Net loss was CNY 301.51 million compared to CNY 306.18 million a year ago. Basic loss per share from continuing operations was CNY 3.27 compared to CNY 4.12 … steinway street pharmacyWebbHinova Pharmaceuticals Inc. New York City Metropolitan Area. 1K followers ... Hinova's oral AR degrader HP518 received FDA clearance … steinway street covid testingWebb22 mars 2024 · Hinova Pharmaceuticals Inc is a Chinese company mainly engaged in the research and development of innovative drugs for critical illnesses. The Company focuses its research on the fields of tumor, metabolic diseases and other critical illnesses. The Company's research platforms include a deuterated drug development platform, a … pinon sage bed breakfast salida coWebb22 feb. 2024 · Hinova Pharmaceuticals USA, Inc. ClinicalTrials.gov Identifier: NCT03850795 Other Study ID Numbers: HC1119-CS-03 : First Posted: February 22, … steinway store near me